UNSPSC 51152036: Mephenesin nicotinate

This classification denotes a muscle relaxant with the molecular formula C16H17NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9490C46O95. Most nations schedule mephenesin nicotinate under HS 29094990 and SITC 51617. As of Q4 2014, MEPHENESIN NICOTINATE remains the US FDA Preferred Term for this commodity. SMILES: CC1=CC=CC=C1OCC(COC(=O)N)O.

UNSPSC 51152036 Mephenesin nicotinate is a Commodity code that nominally describes a muscle relaxant pharmaceutical, but the recent state and local procurement activity tagged to this code does not reflect that scope. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026 with a response deadline of July 26, 2023, seeks Naloxone and Safe Drug Deactivation Systems — emergency opioid-reversal supplies and drug disposal equipment unrelated to mephenesin nicotinate. The mismatch between the code's nominal pharmaceutical classification and the actual goods being procured suggests either a tagging error in the issuing system or a significant gap between the UNSPSC taxonomy and current state and local health and public-safety procurement practice. No additional recent opportunities under this code are available to characterize issuing-body patterns or geographic spread beyond this single Seminole County example.

The Seminole County procurement calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems on an annual basis, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with an optional one-year renewal, and bidders must cover all shipping and delivery costs. Standard compliance requirements include drug-free workplace certification, E-Verify enrollment, workers' compensation insurance, commercial general liability coverage, and professional liability insurance. The procurement was potentially funded through FEMA and subject to federal environmental regulations. Given the mismatch between the code's stated scope and actual procurement activity, this code shows little relevant recent activity for pharmaceutical manufacturers or suppliers working within the mephenesin nicotinate product line.